{"id":"lipid-lowering-drug-statin","safety":{"commonSideEffects":[{"rate":"1–5","effect":"Muscle pain or myalgia"},{"rate":"1–3","effect":"Elevated liver enzymes (transaminitis)"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"},{"rate":"1–3","effect":"Headache"},{"rate":"1–3","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL3354642","moleculeType":"Small molecule","molecularWeight":"1826.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Statins competitively bind to HMG-CoA reductase and block the conversion of HMG-CoA to mevalonate, a critical early step in the cholesterol biosynthetic pathway. This leads to decreased hepatic cholesterol production, upregulation of LDL receptors on liver cells, and enhanced clearance of LDL cholesterol from circulation. Statins also have pleiotropic anti-inflammatory and endothelial-protective effects beyond cholesterol lowering.","oneSentence":"Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:20.603Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and dyslipidemia"},{"name":"Primary and secondary prevention of cardiovascular disease"},{"name":"Reduction of risk of myocardial infarction and stroke"}]},"trialDetails":[{"nctId":"NCT07089589","phase":"","title":"Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2008-01-02","conditions":"Major Adverse Cardiovascular Events, Liver Transplantation","enrollment":6871},{"nctId":"NCT07464574","phase":"","title":"Optimizing Non-statin Agents for ASCVD","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2026-01-16","conditions":"ASCVD Management","enrollment":1000},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT06488105","phase":"PHASE2","title":"Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-08-05","conditions":"Lipid Disorder, Hypercholesterolemia, Cardiovascular Diseases","enrollment":130},{"nctId":"NCT06841536","phase":"NA","title":"Combined Effects of Statins and Exercise on Training Sensitive Health Markers","status":"COMPLETED","sponsor":"University of the Faroe Islands","startDate":"2025-05-01","conditions":"Dyslipidemias","enrollment":120},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT05743387","phase":"NA","title":"Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-05-13","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":252},{"nctId":"NCT05289063","phase":"PHASE1","title":"Vascular Endothelial Dysfunction in Sleep Apnea","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-10-03","conditions":"Obstructive Sleep Apnea of Adult","enrollment":110},{"nctId":"NCT06863545","phase":"NA","title":"Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-22","conditions":"Coronary Artery Disease, CT Angiography, PCSK9","enrollment":3596},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT06740552","phase":"","title":"Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-01-01","conditions":"Multivessel Coronary Artery Disease, Acute Myocardial Infarction (AMI)","enrollment":1862},{"nctId":"NCT04894877","phase":"","title":"ISCHEMIA-EXTEND (Extended Follow-up)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-07","conditions":"Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease","enrollment":5391},{"nctId":"NCT05782777","phase":"NA","title":"Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-04-07","conditions":"Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation","enrollment":4310},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT07344610","phase":"","title":"Effects of Short-term Intensive Statin Therapy on Lipid Levels","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-08","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06855537","phase":"PHASE4","title":"Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-03","conditions":"Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Thin-cap fIbroatheroma","enrollment":2190},{"nctId":"NCT07256171","phase":"","title":"COAST Study - Cholesterol Optimization After Stroke","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-01","conditions":"Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage","enrollment":500},{"nctId":"NCT05910476","phase":"PHASE4","title":"Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2023-05-03","conditions":"Coronary Artery Disease, Dyslipidemias","enrollment":200},{"nctId":"NCT04262206","phase":"PHASE4","title":"Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-09-01","conditions":"Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases","enrollment":20000},{"nctId":"NCT06423365","phase":"NA","title":"A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2024-10-24","conditions":"Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Cardiovascular Diseases","enrollment":816},{"nctId":"NCT03936361","phase":"PHASE3","title":"Statins In Intracerbral Hemorrhage","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-06-10","conditions":"Intracerebral Hemorrhage","enrollment":1456},{"nctId":"NCT07180745","phase":"PHASE4","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2025-11-01","conditions":"Non-alcoholic Fatty Liver Disease NAFLD, Non-alcoholic Steatohepatitis NASH","enrollment":400},{"nctId":"NCT06767345","phase":"PHASE4","title":"Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2025-05-12","conditions":"Coronary Artery Disease, Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic","enrollment":408},{"nctId":"NCT06520891","phase":"","title":"\"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease\"","status":"RECRUITING","sponsor":"Fayoum University","startDate":"2024-06-01","conditions":"2 Drugs Are Statin and SGLT2i","enrollment":90},{"nctId":"NCT07148037","phase":"","title":"Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-09-01","conditions":"Hyperlipidemias","enrollment":150},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT07064135","phase":"NA","title":"Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery","status":"NOT_YET_RECRUITING","sponsor":"Barmherzige Brüder Linz","startDate":"2025-08-04","conditions":"Dyslipidaemias, Carotid Artery Stenoses","enrollment":50},{"nctId":"NCT06902740","phase":"PHASE4","title":"PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-09-01","conditions":"Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic Plaque","enrollment":300},{"nctId":"NCT06722521","phase":"PHASE4","title":"GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-09","conditions":"Primary Prevention, Vascular Calcification","enrollment":7435},{"nctId":"NCT04992065","phase":"PHASE2","title":"A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-08-03","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":267},{"nctId":"NCT06996223","phase":"EARLY_PHASE1","title":"A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-06-01","conditions":"Aortic Stenosis, PCSK9 Inhibitor, Calcified Aortic Valve Disease","enrollment":316},{"nctId":"NCT03110432","phase":"","title":"Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2017-05-18","conditions":"Dyslipoproteinemias, Hypercholesterolemia, Familial, Familial Hypercholesterolemia - Homozygous","enrollment":1695},{"nctId":"NCT05178420","phase":"NA","title":"STREAM Trial - Statins in Multimorbid Older Adults Without Cardiovascular Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-11-16","conditions":"Statin Treatment for Primary Prevention","enrollment":1881},{"nctId":"NCT06102863","phase":"PHASE2","title":"Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2023-04-01","conditions":"Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":38},{"nctId":"NCT06865885","phase":"PHASE4","title":"LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-04-03","conditions":"Drug Interactions, Primary Prevention, Cardiometabolic Syndrome","enrollment":100},{"nctId":"NCT05368545","phase":"NA","title":"Influence of Lipid Lowering on Impaired Coronary Flow","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2020-05-15","conditions":"Coronary Artery Disease","enrollment":109},{"nctId":"NCT06604117","phase":"","title":"Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-10-17","conditions":"Ischemic Stroke, Atherosclerosis of Artery, Lipid Disorder","enrollment":200},{"nctId":"NCT06738758","phase":"","title":"Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)","status":"RECRUITING","sponsor":"Yun Dai Chen","startDate":"2024-12-16","conditions":"Acute Coronary Syndromes","enrollment":6000},{"nctId":"NCT06280976","phase":"PHASE4","title":"Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2024-03-01","conditions":"Coronary Artery Disease, Atherosclerosis, Heart Attack","enrollment":""},{"nctId":"NCT05255094","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia","status":"COMPLETED","sponsor":"Akeso","startDate":"2021-11-03","conditions":"Hyperlipidemia","enrollment":464},{"nctId":"NCT05260411","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia","status":"COMPLETED","sponsor":"Akeso","startDate":"2022-01-26","conditions":"Hyperlipidemia","enrollment":246},{"nctId":"NCT02378805","phase":"","title":"Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome","status":"RECRUITING","sponsor":"University Hospital Goettingen","startDate":"1995-07","conditions":"Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease","enrollment":800},{"nctId":"NCT06856772","phase":"PHASE4","title":"Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial","status":"NOT_YET_RECRUITING","sponsor":"Tor Biering-Sørensen","startDate":"2025-02-28","conditions":"Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease","enrollment":42000},{"nctId":"NCT05255458","phase":"PHASE3","title":"A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia","status":"COMPLETED","sponsor":"Akeso","startDate":"2021-11-04","conditions":"Hyperlipidemia","enrollment":122},{"nctId":"NCT06821711","phase":"NA","title":"Optimal LDL-C Target in High-risk Patients After PCI","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-02-20","conditions":"Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention","enrollment":12000},{"nctId":"NCT06031610","phase":"","title":"Revascularization Effect on CSVD Burden in Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Zhejiang Provincial People's Hospital","startDate":"2023-06-10","conditions":"Carotid Artery Stenosis, Cerebral Small Vessel Diseases","enrollment":1000},{"nctId":"NCT06804980","phase":"PHASE4","title":"DESIFOR-EXPAND (MHIF)","status":"RECRUITING","sponsor":"Minneapolis Heart Institute Foundation","startDate":"2025-02-01","conditions":"Statin Therapy, Statin Adverse Reaction, Statin","enrollment":100},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT06785740","phase":"","title":"Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-11-01","conditions":"Ischemic Stroke, TIA","enrollment":300},{"nctId":"NCT06785727","phase":"PHASE4","title":"StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Prof. dr. Nathalie van der Velde","startDate":"2025-02-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":612},{"nctId":"NCT05251129","phase":"NA","title":"Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2025-01","conditions":"Vasculopathy","enrollment":""},{"nctId":"NCT06588231","phase":"NA","title":"Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-10-17","conditions":"Coronary Heart Disease","enrollment":200},{"nctId":"NCT04554953","phase":"","title":"A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2020-04-13","conditions":"Hypertension and Dyslipidemia","enrollment":10877},{"nctId":"NCT04656028","phase":"NA","title":"Genetic Testing and Motivational Counseling for FH","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2020-06-15","conditions":"Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2","enrollment":180},{"nctId":"NCT03308578","phase":"PHASE1, PHASE2","title":"Statins and CPAP in Adipose Tissue of OSA","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-01-08","conditions":"Sleep Apnea, Obstructive","enrollment":50},{"nctId":"NCT06730802","phase":"NA","title":"Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2025-01-01","conditions":"Myocardial Ischaemic Syndrome, Coronary Heart Disease","enrollment":400},{"nctId":"NCT04826237","phase":"PHASE4","title":"Oral Statins and Protection From Hearing Loss","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-02-09","conditions":"Sudden Sensorineural Hearing Loss","enrollment":100},{"nctId":"NCT06684366","phase":"","title":"Chronic Coronary Syndrome Real Practice and Guidelines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assiut University","startDate":"2024-10-22","conditions":"Coronary Arterial Disease (CAD)","enrollment":300},{"nctId":"NCT04369664","phase":"PHASE4","title":"CHOlesterol Lowering and Residual Risk in Type 2 Diabetes","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-08-12","conditions":"Type 2 Diabetes","enrollment":151},{"nctId":"NCT06614049","phase":"NA","title":"AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2024-06-10","conditions":"Hyperlipidemia, Medication Nonadherence","enrollment":450},{"nctId":"NCT06622304","phase":"","title":"Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels","status":"COMPLETED","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2024-04-01","conditions":"Hypertension, Dyslipidemias, Inflammatory Response","enrollment":250736},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT03122639","phase":"EARLY_PHASE1","title":"Endothelial Function in Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-09-01","conditions":"Obstructive Sleep Apnea of Adult","enrollment":106},{"nctId":"NCT06520904","phase":"PHASE4","title":"Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography","status":"RECRUITING","sponsor":"First Affiliated Hospital of Xinjiang Medical University","startDate":"2024-07-01","conditions":"Coronary Artery Disease, Optical Coherence Tomography","enrollment":396},{"nctId":"NCT00652847","phase":"PHASE4","title":"Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Hypercholesterolemia","enrollment":1140},{"nctId":"NCT00166530","phase":"PHASE4","title":"EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Atherosclerosis","enrollment":367},{"nctId":"NCT02668016","phase":"PHASE4","title":"Self-Assessment Method for Statin Side-effects Or Nocebo","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-03","conditions":"Adverse Effects, Cardiovascular Diseases, Hyperlipidemias","enrollment":60},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT06468254","phase":"PHASE2","title":"An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer","status":"RECRUITING","sponsor":"Anhui Provincial Cancer Hospital","startDate":"2024-06-30","conditions":"Ovarian Cancer","enrollment":500},{"nctId":"NCT04847752","phase":"","title":"Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2021-03-01","conditions":"Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis)","enrollment":1000},{"nctId":"NCT05285085","phase":"","title":"Real World Evidence Study of Statin Use in Brazil","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2021-11-19","conditions":"Cardiovascular Diseases, Myocardial Infarction, Stroke","enrollment":2133900},{"nctId":"NCT03882905","phase":"PHASE3","title":"A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-01-31","conditions":"Primary Hypercholesterolemia","enrollment":769},{"nctId":"NCT04968509","phase":"PHASE3","title":"Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2024-03-22","conditions":"Aortic Stenosis","enrollment":160},{"nctId":"NCT04770389","phase":"PHASE2","title":"Randomized Study of Obicetrapib in Combination With Ezetimibe","status":"COMPLETED","sponsor":"NewAmsterdam Pharma","startDate":"2021-02-23","conditions":"Dyslipidemias, High Cholesterol, Hypercholesterolemia","enrollment":112},{"nctId":"NCT06381947","phase":"PHASE4","title":"Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients","status":"NOT_YET_RECRUITING","sponsor":"University of Salerno","startDate":"2024-05-01","conditions":"Dyslipidemias, Statin Adverse Reaction, Cardiovascular Diseases","enrollment":130},{"nctId":"NCT06367322","phase":"","title":"Statins and Post-ERCP Acute Pancreatitis (Stark Project)","status":"COMPLETED","sponsor":"Hospital General Universitario de Alicante","startDate":"2017-01-10","conditions":"Post-ERCP Acute Pancreatitis","enrollment":1016},{"nctId":"NCT05361421","phase":"PHASE4","title":"Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2022-07-19","conditions":"Cardiovascular Disease","enrollment":1200},{"nctId":"NCT04245644","phase":"","title":"Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massimo Falconi","startDate":"2019-03-02","conditions":"Disease Free Survival, Overall Survival, Pancreatic Cancer","enrollment":800},{"nctId":"NCT05587621","phase":"NA","title":"Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)","status":"NOT_YET_RECRUITING","sponsor":"Jena University Hospital","startDate":"2024-04-01","conditions":"ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction, LDL-cholesterol","enrollment":300},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT06262685","phase":"PHASE4","title":"Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2024-03-04","conditions":"Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction","enrollment":216},{"nctId":"NCT02931188","phase":"","title":"The Effect of Anacetrapib on Vascular Function and Arterial Stiffness","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-01","conditions":"Atherosclerotic Cardiovascular Disease, Vascular Disease","enrollment":103},{"nctId":"NCT04857632","phase":"PHASE2, PHASE3","title":"Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2021-08-06","conditions":"Intracerebral Hemorrhage, Statins","enrollment":98},{"nctId":"NCT05782881","phase":"NA","title":"High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2023-01-15","conditions":"Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease","enrollment":16000},{"nctId":"NCT04721795","phase":"PHASE2, PHASE3","title":"Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)","status":"COMPLETED","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2021-01-19","conditions":"Tuberculosis, Pulmonary, Tuberculosis","enrollment":150},{"nctId":"NCT04986241","phase":"","title":"The Association of Statins on Cardiorespiratory Fitness and Exercise Adaptation","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-09-20","conditions":"Statin Adverse Reaction","enrollment":18557},{"nctId":"NCT05482386","phase":"NA","title":"STREAM Trial - Biomarker","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2022-11-21","conditions":"Statin Treatment for Primary Prevention","enrollment":500},{"nctId":"NCT05482399","phase":"NA","title":"STREAM Trial - Subclinical Atherosclerosis","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2022-06-21","conditions":"Statin Treatment for Primary Prevention","enrollment":500},{"nctId":"NCT02817230","phase":"","title":"Effect of Statins on Trained Immunity","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2015-06","conditions":"Atherosclerosis","enrollment":45},{"nctId":"NCT05624658","phase":"NA","title":"Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS","status":"UNKNOWN","sponsor":"Samara Regional Cardiology Dispensary","startDate":"2022-09-02","conditions":"Dyslipidemias","enrollment":200},{"nctId":"NCT06134635","phase":"","title":"Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-12-01","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT00810979","phase":"PHASE2","title":"Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia","status":"COMPLETED","sponsor":"Response Pharmaceuticals","startDate":"2009-01","conditions":"Hyperlipidemia","enrollment":133},{"nctId":"NCT05623995","phase":"PHASE4","title":"Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)","status":"UNKNOWN","sponsor":"Lin Zhao","startDate":"2022-12-15","conditions":"In-stent Restenosis, Major Adverse Cardiovascular Events","enrollment":200},{"nctId":"NCT06096909","phase":"NA","title":"Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-11-01","conditions":"Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":3684},{"nctId":"NCT04719221","phase":"PHASE4","title":"Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Korea University Anam Hospital","startDate":"2021-03-01","conditions":"Clinical Trial, Acute Coronary Syndrome","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"lipid-lowering drug(Statin)","genericName":"lipid-lowering drug(Statin)","companyName":"First Affiliated Hospital of Wenzhou Medical University","companyId":"first-affiliated-hospital-of-wenzhou-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood. Used for Hypercholesterolemia and dyslipidemia, Primary and secondary prevention of cardiovascular disease, Reduction of risk of myocardial infarction and stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}